← Leaderboards
Michael Vincent Quinn
Hs-Design, Inc.
$1,878,258
Attributed
$1,878,258
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,878,258 · 1
By mechanism
N44$1,878,258 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Antineoplastic Agents”
- Leonard Freedman · Leidos Biomedical Research, Inc.$243,278,693
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,166,869
- Leonard Freedmand · Leidos Biomedical Research, Inc.$54,796,285
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$29,626,259
- James Jeffrey Sahn · 4e Therapeutics Inc.$7,126,294
- Jeffrey H. Price · Vala Sciences, Inc.$5,562,326
Research focus
Antineoplastic AgentsBaseCancer TherapyCapsuleCaregiversChildChildhoodChildhood Cancer TreatmentClinical ResearchDeglutitionDesignDoseFormulationInstitutional Review BoardsLeadLiquid FormulationLiquid SubstanceMalignant Childhood NeoplasmMalignant NeoplasmsMasksMicrospheresOncologyOralPerformance